These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 19077118

  • 21. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
    Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, Yamanouchi Y, Tomita M, Inada T, Ozaki N, Iwata N.
    Schizophr Res; 2009 May; 110(1-3):140-8. PubMed ID: 19329282
    [Abstract] [Full Text] [Related]

  • 22. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.
    Caldú X, Vendrell P, Bartrés-Faz D, Clemente I, Bargalló N, Jurado MA, Serra-Grabulosa JM, Junqué C.
    Neuroimage; 2007 Oct 01; 37(4):1437-44. PubMed ID: 17689985
    [Abstract] [Full Text] [Related]

  • 23. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y, Chauhan C, Verma B, Manduva V, Mukherjee O, Purushottam M, Sharma A, Jain S, Brahmachari SK, Kukreti R.
    Pharmacogenomics; 2009 Mar 01; 10(3):385-97. PubMed ID: 19290789
    [Abstract] [Full Text] [Related]

  • 24. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J, Schmitz N, van Amelsvoort T, Moeton M, Baas F, Linszen D.
    Genes Brain Behav; 2008 Feb 01; 7(1):61-9. PubMed ID: 17504246
    [Abstract] [Full Text] [Related]

  • 25. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A, Benseler F, Hannke K, Sperling S, Schwerdtfeger D, Thanhäuser I, Gerchen MF, Ghorbani M, Gutwinski S, Hilmes C, Leppert R, Ronnenberg A, Sowislo J, Stawicki S, Stödtke M, Szuszies C, Reim K, Riggert J, Eckstein F, Falkai P, Bickeböller H, Nave KA, Brose N, Ehrenreich H.
    Arch Gen Psychiatry; 2010 Sep 01; 67(9):879-88. PubMed ID: 20819981
    [Abstract] [Full Text] [Related]

  • 26. COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.
    Haraldsson HM, Ettinger U, Magnusdottir BB, Sigmundsson T, Sigurdsson E, Ingason A, Petursson H.
    Psychiatry Res; 2009 Sep 30; 169(2):173-5. PubMed ID: 19647329
    [Abstract] [Full Text] [Related]

  • 27. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
    Lewandowski KE.
    Harv Rev Psychiatry; 2007 Sep 30; 15(5):233-44. PubMed ID: 17924258
    [Abstract] [Full Text] [Related]

  • 28. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR, Kim JH, Kim SJ, Lee D, Min SK.
    Eur Neuropsychopharmacol; 2008 Nov 30; 18(11):820-5. PubMed ID: 18789857
    [Abstract] [Full Text] [Related]

  • 29. Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.
    Liu X, Hong X, Chan RC, Kong F, Peng Z, Wan X, Wang C, Cheng L.
    Psychiatry Res; 2013 Oct 30; 209(3):431-8. PubMed ID: 23598060
    [Abstract] [Full Text] [Related]

  • 30. Association of the 3' region of COMT with schizophrenia in Taiwan.
    Chien YL, Liu CM, Fann CS, Liu YL, Hwu HG.
    J Formos Med Assoc; 2009 Apr 30; 108(4):301-9. PubMed ID: 19369177
    [Abstract] [Full Text] [Related]

  • 31. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H.
    Brain; 2006 Feb 30; 129(Pt 2):399-410. PubMed ID: 16330500
    [Abstract] [Full Text] [Related]

  • 32. [Molecular genetics of cognitive deficit in schizophrenia].
    Golimbet VE.
    Mol Biol (Mosk); 2008 Feb 30; 42(5):830-9. PubMed ID: 18988532
    [Abstract] [Full Text] [Related]

  • 33. Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials.
    Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O, Mulert C, Hegerl U, Rujescu D.
    Hum Psychopharmacol; 2008 Mar 30; 23(2):115-20. PubMed ID: 18081002
    [Abstract] [Full Text] [Related]

  • 34. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):81-5. PubMed ID: 19818823
    [Abstract] [Full Text] [Related]

  • 35. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.
    Neurobiol Aging; 2007 Aug 01; 28(8):1231-8. PubMed ID: 16837108
    [Abstract] [Full Text] [Related]

  • 36. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study.
    Poyurovsky M, Michaelovsky E, Frisch A, Knoll G, Amir I, Finkel B, Buniak F, Hermesh H, Weizman R.
    Neurosci Lett; 2005 Nov 25; 389(1):21-4. PubMed ID: 16043283
    [Abstract] [Full Text] [Related]

  • 37. [Vulnerability to schizophrenia. I: Familial nature of of neuropsychologic indicators].
    d'Amato T, Saoud M, Triboulet P, Bertaud JP, Dalery J.
    Encephale; 1998 Nov 25; 24(5):442-8. PubMed ID: 9850818
    [Abstract] [Full Text] [Related]

  • 38. Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia.
    Rybakowski JK, Borkowska A, Skibinska M, Hauser J.
    Psychiatr Genet; 2007 Jun 25; 17(3):201-4. PubMed ID: 17417065
    [Abstract] [Full Text] [Related]

  • 39. More evidence supports the association of PPP3CC with schizophrenia.
    Liu YL, Fann CS, Liu CM, Chang CC, Yang WC, Hung SI, Yu SL, Hwang TJ, Hsieh MH, Liu CC, Tsuang MM, Wu JY, Jou YS, Faraone SV, Tsuang MT, Chen WJ, Hwu HG.
    Mol Psychiatry; 2007 Oct 25; 12(10):966-74. PubMed ID: 17339875
    [Abstract] [Full Text] [Related]

  • 40. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.
    Matsuzaka CT, Christofolini D, Ota VK, Gadelha A, Berberian AA, Noto C, Mazzotti DR, Spindola LM, Moretti PN, Smith MAC, Melaragno MI, Belangero SI, Bressan RA.
    Braz J Psychiatry; 2017 Oct 25; 39(4):302-308. PubMed ID: 28273278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.